Location History:
- Houston, TX (US) (1997 - 2001)
- New York, NY (US) (2015 - 2023)
Company Filing History:
4 out of 270 
3 out of 601 
1 out of 45 
Years Active: 1997-2024
Title: Innovations of Shu-Hsia Chen in Antibody Development
Introduction
Shu-Hsia Chen is a prominent inventor based in Houston, TX, known for her significant contributions to the field of antibody research. With a total of 7 patents, she has made remarkable strides in developing antibodies that target specific proteins involved in various diseases.
Latest Patents
Among her latest patents are the "Anti-LILRB2 antibodies and methods of use thereof." This patent discloses antibodies and antibody fragments that specifically bind to LILRB2. The patent also includes compositions comprising these antibodies and methods of use, such as targeting tumors, treating asthma, and removing infected cells. Another notable patent is the "Anti-LILRB3 antibodies and methods of use thereof," which similarly focuses on antibodies that bind to LILRB3 and their applications in medical treatments.
Career Highlights
Shu-Hsia Chen has worked at prestigious institutions, including the Icahn School of Medicine at Mount Sinai and Baylor College of Medicine. Her work has significantly advanced the understanding and application of antibodies in therapeutic settings.
Collaborations
Throughout her career, she has collaborated with notable professionals, including Savio L Woo and Savio L C Woo, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Shu-Hsia Chen's innovative work in antibody development has the potential to transform treatments for various diseases, showcasing her importance in the field of biomedical research.